Solid Biosciences is trading 7.47% up in pre-market at $10.50 after no confirmed company-specific catalyst was identified for August 31, 2026.

  • Latest company disclosure remains its August 6 second-quarter report and business update.
  • The investor-relations page shows no newer press release.
  • Broader markets are mixed to slightly lower, so macro sentiment does not clearly explain the upward move; the catalyst remains unconfirmed.